How Many Patients Suffering Major Trauma Would be Eligible for a Pre-hospital Transfusion

NCT06494293 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2024-12-31

No results posted yet for this study

Summary

The aim of the study is to measure the number of patients being cared for by a medical team for major trauma who could benefit from a transfusion labile blood products and thus provide a scientific argument in favour of supplying labile blood products to pre-hospital

Conditions

  • Trauma Injury

Interventions

OTHER

Data Collection

Collection of medical data from MICU intervention file and patient medical files from participating centres

Sponsors & Collaborators

  • Direction Centrale du Service de Santé des Armées

    collaborator OTHER
  • Hôpital NOVO

    lead OTHER

Principal Investigators

  • Dr Dorian WOLFF · Hôpital NOVO

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-30
Primary Completion
2025-05-31
Completion
2025-05-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06494293 on ClinicalTrials.gov